Lipoamino acids and lipopeptides as potential 5- and 12-lipoxygenase inhibitors
Presenz, P.
Die Pharmazie 52(2): 164-165
1997
ISSN/ISBN: 0031-7144 PMID: 9122277 Document Number: 475673
Document emailed within 1 workday
Related Documents
Lototskaia, L.S.; Naĭdenova, I.I.; Il'iasheva, L.M.; Poda, G.I.; Kornilov, A.I. 1989: Soy lipoxygenase as the object for the primary testing of potential inhibitors of leukotriene biosynthesis Farmakologiia i Toksikologiia 52(2): 59-62Falkenhein, S.F.; Macdonald, H.; Huber, M.M.; Koch, D.; Parker, C.W. 1980: Effect of the 5-hydroperoxide of eicosatetraenoic acid and inhibitors of the lipoxygenase pathway on the formation of slow reacting substance by rat basophilic leukemia cells; direct evidence that slow reacting substance is a product of the lipoxygenase pathway Journal of Immunology 125(1): 163-168
Gápovský, M.; Remko, M. 2002: Inhibitors of 5-lipoxygenase Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 51(2): 55-62
Nuhn, P.; Büge, A.; Köhler, T.; Lettau, H.; Schneider, R. 1991: Trends in the development of lipoxygenase inhibitors Die Pharmazie 46(2): 81-88
Grupe, R.; Ziska, T.; Richter, A.; Böhme, B.; Göres, E. 1988: Lipoxygenase inhibitors and mast cell degranulation Biomedica Biochimica Acta 47(12): 955-963
Bibikova, M.V.; Spiridonova, I.A.; Danilenko, A.N.; Kim, Y.A.; Korystova, A.F.; Shaposhnikova, V.V.; Korystov, Y.N. 2016: Screening of Organisms Producing Inhibitors of 15-Lipoxygenase Among Micromycetes Antibiotiki i Khimioterapiia 61(7-8): 3-9
Butovich, I.A.; Soloshonok, V.A.; Solodenko, V.A.; Kukhar', V.P. 1990: Activation of 5-lipoxygenase by lipophilic n-alkyl-containing acids--an allosteric process Bioorganicheskaia Khimiia 16(2): 270-271
Evans, J.F.; Lévillé, C.; Mancini, J.A.; Prasit, P.; Thérien, M.; Zamboni, R.; Gauthier, J.Y.; Fortin, R.; Charleson, P.; MacIntyre, D.E. 1991: 5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors Molecular Pharmacology 40(1): 22-27
Beno, D.W.; Mullen, J.; Davis, B.H. 1995: Lipoxygenase inhibitors block PDGF-induced mitogenesis: a MAPK-independent mechanism that blocks fos and egr American Journal of Physiology 268(3 Pt 1): C604-C610
Ishihara, Y.; Uchida, Y.; Kitamura, S.; Takaku, F. 1983: Effect of lipoxygenase inhibitors, AA-861 and T-22083, on chemical mediators release from sensitized guinea pig lung tissue Nihon Kyobu Shikkan Gakkai Zasshi 21(10): 984-987
Zarnack, S.; Bekemeier, H.; Giessler, A.J. 1988: Inhibition of arachidonic acid-induced ear edema in the mouse with lipoxygenase-, cyclo-oxygenase- and dual inhibitors Die Pharmazie 43(5): 337-338
Kühn, H.; Belkner, J.; Wiesner, R. 1990: Metabolism of polyenoic fatty acids by rabbit reticulocytes. Intracellular action of the erythroid lipoxygenase on membrane lipids Biomedica Biochimica Acta 49(2-3): S25-S30
Rahman, A.; Imran, H.; Iqbal, L.; STaqvi, S.I.H.; Fatima, N.; Yaqeen, Z. 2016: Dry and ripe fruit of Aegle marmelos. L: a potent source of antioxidant, lipoxygenase inhibitors and free radical scavenger Pakistan Journal of Pharmaceutical Sciences 29(4): 1127-1131
Kelly, J.P.; Johnson, M.C.; Parker, C.W. 1979: Effect of inhibitors of arachidonic acid metabolism on mitogenesis in human lymphocytes: possible role of thromboxanes and products of the lipoxygenase pathway Journal of Immunology 122(4): 1563-1571
Bekemeier, H.; Hirschelmann, R.; Langner, A.; Giessler, A.J.; Krause, E.; Funke, T.; Hänsel, F.; Schmidt, K.; Zarnack, S.; Schumann, H.H. 1989: The pharmacology of the lipoxygenase inhibitors oxphaman (1-(2,5-dihydroxybenzylidene)aminoadamantane) and oxphalin (1-(3,4-dihydroxybenzylidene)-2,4,6-trimethylaniline Die Pharmazie 44(8): 550-555
Nyby, M.D.; Sasaki, M.; Ideguchi, Y.; Wynne, H.E.; Hori, M.T.; Berger, M.E.; Golub, M.S.; Brickman, A.S.; Tuck, M.L. 1996: Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation Journal of Pharmacology and Experimental Therapeutics 278(2): 503-509
Tang, J.-s.; Gao, H.; Dai, Y.; Hong, K.; Yao, X.-s. 2008: Progress on the studies of cyclic lipopeptides Yao Xue Xue Bao 43(9): 873-883
Szałapata, K.; Osińska-Jaroszuk, M.; Jarosz-Wilkołazka, A. 2017: Inhibitors of enzymes with potential medical applications Postepy Biochemii 63(4): 261-268
Ho, L.; Pasinetti, G.Maria. 2001: The potential of selective COX-2 inhibitors in inflammatory and other diseases Drugs of Today 37(3): 181-185
Caliendo, G.; Fiorino, F.; Grieco, P.; Perissutti, E.; De Luca, S.; Giuliano, A.; Santelli, G.; Califano, D.; Severino, B.; Santagada, V. 1999: Synthesis and biological activity of pseudopeptides inhibitors of Ras farnesyl transferase containing unconventional amino acids Farmaco 54(11-12): 785-790